Any idea of how much of the B2B revenue would be recurring and the frequency of those sales? For instance if a company doesn't re-order for another three months, you would need to divide that revenue by three to arrive at monthly averages. April was wonderful for B2B sales, but I'd like some more information to get a clearer picture for the purpose of making forward projections. I do agree that on face value the SP is looking cheap.
- Forums
- ASX - By Stock
- ZNO
- Trading way under its current true value
Trading way under its current true value, page-2
- There are more pages in this discussion • 88 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ZNO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
-0.004(12.9%) |
Mkt cap ! $5.771M |
Open | High | Low | Value | Volume |
3.1¢ | 3.1¢ | 2.7¢ | $8.434K | 292.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 437298 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 437298 | 0.027 |
4 | 870652 | 0.026 |
8 | 760000 | 0.025 |
3 | 128800 | 0.024 |
1 | 50000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 100000 | 1 |
0.034 | 150000 | 1 |
0.040 | 72000 | 2 |
0.043 | 54026 | 1 |
0.052 | 1875 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
2.9¢ |
  |
Change
-0.004 ( 6.45 %) |
|||
Open | High | Low | Volume | ||
3.1¢ | 3.1¢ | 2.9¢ | 85245 | ||
Last updated 11.35am 06/05/2024 ? |
Featured News
ZNO (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online